From: Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers
 | High Feasibility | Low Immediate Feasibility |
---|---|---|
High Priority | • Establish clear and well documented conflict of interest (COI) guidelines • Define penalties for infringement of COI guidelines and enforce them consistently • Make internal and external audits of drug regulatory agencies publicly available • Monitor of patent and proprietary medicines dealers more closely • Make terms of reference and criteria for membership of the drug registration committee publicly available | • Re-allocation of financial resources to provide more up-to-date technology • Increase security (preferably by electronic alarm systems, video cameras etc) at drug storage facilities and warehouses • Implementing incentives to favour high-quality locally manufactured drug products |
Low Priority | • Regular rotation of inspectors to different geographical locations • Decentralize NAFDAC inspectorate offices within states and increase the number of local government offices | • Potential eradication of the sale of drugs by non-pharmacists • Improve the division of responsibility for drugs among the various departments of the Federal Ministry of Health |